ServicesCommercial Services & SuppliesDiversified Commercial Services

Zenlabs Ethica Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 28 filings·Updated 14 Aug 2026
Showing 10 of 28 filings.
14 Aug 20261 filing
Company UpdateNewspaper Publication

Submission of newspaper advertisement for publication of extract of audited financial results of quarter ended 30th June 2026.

Filed 13:23View Source
12 Aug 20261 filing
ResultFinancial Results

Zenlabs Ethica Q1 FY27: Revenue ₹1,417.66 lakh; PAT ₹−57.12 lakh; single-segment pharma trading

Financials (Q1 FY27)

  • Revenue from operations ₹1,417.66 lakh in Q1 FY27; up ~23.5% YoY.
  • Total income ₹1,417.72 lakh; YoY growth ~23.5%.
  • Expenditure ₹1,473.28 lakh; up ~28.8% YoY.
  • PBT ₹−55.55 lakh; vs ₹4.45 lakh in the prior year.
  • Tax: deferred ₹1.56 lakh; PAT ₹−57.12 lakh.
  • EPS Basic/Diluted ₹−0.88 for Q1 FY27.
  • Board approved unaudited results; limited review report unmodified.
  • Single segment: trading of pharmaceuticals formulations.
Filed 18:09View Source
7 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms dematerialisation processing, listing of securities, and owner update

Dematerialisation processing and listing status

  • Dematerialisation requests were confirmed to the depositories as accepted or rejected.
  • Securities dematerialised have been listed on the stock exchange where the earlier issues are listed.
  • Physical certificates dematerialised were mutilated and cancelled, with the depository name updated as registered owner within prescribed timeline.
Filed 17:15View Source
1 Jun 20261 filing
Company UpdateNewspaper Publication

Submission of Newspaper Advertisement for publication of extract of audited financial results of quarter and year ended 31st March 2026

Filed 12:09View Source
29 May 20261 filing
Board MeetingOutcome of Board Meeting

Zenlabs Ethica Ltd - 530697 - Board Meeting Outcome for As Per Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements), 2015

Financial results

  • Audited standalone financial results approved for quarter and year ended 31 March 2026.
  • Auditors issued an unmodified opinion on the audited standalone results.
  • Quarterly revenue from operations was ₹1,058.41 lakh; annual revenue was ₹4,692.25 lakh.
  • Annual profit after tax was a loss of ₹193.56 lakh; quarterly PAT was ₹0.11 lakh.
  • Cash and cash equivalents closed at ₹289.66 lakh as at 31 March 2026.

Other statements

  • Audited standalone balance sheet and cash flow statement for year ended 31 March 2026 were approved.
  • The company reported one operating segment: trading of pharmaceutical formulations.
  • Management said labour code changes had no material financial impact for FY2025-26.

Board decisions

  • Re-appointed M/s Jaspreet Dhawan & Associates as secretarial auditor for FY2026-27.
  • Re-appointed M/s Anu & Associates as internal auditor for FY2026-27.

Management changes

  • Noted resignation of Mr. Amit Kumar as Company Secretary and Compliance Officer, effective 2 March 2026.
  • Appointed Mr. Nikunj Goel as Company Secretary and Compliance Officer, effective 29 May 2026.
Filed 17:20View Source
7 Apr 20261 filing
Company UpdateGeneral

Declaration under Regulation 31(4) of SEBI (Substantial Asquisiton of Shares and Takeover) Regulations,2011 (''SAST Regulations'') for the non-encumbrance of shares during the financial ....

Filed 11:47View Source
30 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

The trading window will remain closed for all Directors/Promoters/Designated persons and their immediate relatives of the company from Wednesday 01st April,2026 till 48 hours after declaration ....

Filed 13:20View Source
2 Mar 20262 filings
Company UpdateChange in Management

Zenlabs Ethica Ltd - 530697 - Announcement under Regulation 30 (LODR)-Change in Management

Management Change

  • Mr. Amit Kumar resigned as Company Secretary & Compliance Officer, effective March 2, 2026.
  • Resignation submitted on February 23, 2026, with a 7-day notice period.
  • Mr. Kumar confirmed no other material reasons for resignation beyond personal reasons.
Filed 17:21View Source
Company UpdateResignation of Company Secretary / Compliance Officer

Intimation of Resignation of Company Secretary and Compliance Officer of the Company

Filed 17:08View Source
9 Feb 20261 filing
Company UpdateNewspaper Publication

Submission of Newspaper advertisement for the publication of extract of Un-audited financial results for the quarter and nine months ended on 31st December 2025

Filed 13:36View Source
Showing 10 of 28 filings